Your institution may have access to this item. Find your institution then sign in to continue.
Title
Oraya device receives CE mark to treat choroidal metastases.
Abstract
The article reports on the Conformite Europeenne (CE) marking given to the Oraya IRay Radiotheraphy system from Oraya Therapeutics for the treatment of eye cancer choroidal metastases as expansion of the prior approval for the wet age-related macular degeneration (AMD) treatment of Oraya Therapeutics.